| 臺大學術典藏 |
2020-03-07T06:56:14Z |
Histologic Transformation in a Patient with Lung Cancer Treated with Chemotherapy and Pembrolizumab
|
Hsu C.-L.;Chen K.-Y.;Kuo S.-W.;Yih-Leong Chang; Hsu C.-L.; Chen K.-Y.; Kuo S.-W.; YIH-LEONG CHANG |
| 臺大學術典藏 |
2020-03-07T06:56:12Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Yih-Leong Chang;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; YIH-LEONG CHANG; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2020-03-07T06:56:11Z |
IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer
|
Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; YIH-LEONG CHANG; Yu C.-J.; Shih J.-Y.; Wu S.-G.;Chang T.-H.;Tsai M.-F.;Liu Y.-N.;Hsu C.-L.;Yih-Leong Chang;Yu C.-J.;Shih J.-Y.; Wu S.-G.; Chang T.-H. |
| 臺大學術典藏 |
2020-03-07T06:56:09Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Yih-Leong Chang;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-03-06T08:24:45Z |
Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma
|
Shen Y.-C.;Hsu C.-L.;Yung-Ming Jeng;Ho M.-C.;Ho C.-M.;Yeh C.-P.;Yeh C.-Y.;Hsu M.-C.;Hu R.-H.;Cheng A.-L.; Shen Y.-C.; Hsu C.-L.; YUNG-MING JENG; Ho M.-C.; Ho C.-M.; Yeh C.-P.; Yeh C.-Y.; Hsu M.-C.; Hu R.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-06T05:26:05Z |
Histologic Transformation in a Patient with Lung Cancer Treated with Chemotherapy and Pembrolizumab
|
Hsu C.-L.; Chen K.-Y.; Kuo S.-W.; YIH-LEONG CHANG |
| 臺大學術典藏 |
2020-03-06T05:26:04Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; YIH-LEONG CHANG; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2020-03-06T05:26:02Z |
IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer
|
Wu S.-G.; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; YIH-LEONG CHANG; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-06T05:26:00Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-03-05T08:38:05Z |
Impaired exercise capacity in diabetic patients after coronary bypass surgery: Effects of diastolic and endothelial function
|
Wu Y.-W.;Hsu C.-L.;Shoei-Shen Wang;Tsai M.-W.;Chu S.-H.;Chen Y.-S.;Yang W.-S.;Wu Y.-T.; Wu Y.-W.; Hsu C.-L.; SHOEI-SHEN WANG; Tsai M.-W.; Chu S.-H.; Chen Y.-S.; Yang W.-S.; Wu Y.-T. |
| 臺大學術典藏 |
2020-03-05T03:20:09Z |
Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma
|
Sahu D.; Hsu C.-L.; Lin C.-C.; Yang T.-W.; WEN-MING HSU; Ho S.-Y.; Juan H.-F.; Huang H.-C. |
| 臺大學術典藏 |
2020-03-05T03:20:09Z |
Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data
|
Hsu C.-L.; Chang H.-Y.; Chang J.-Y.; WEN-MING HSU; Huang H.-C.; Juan H.-F. |
| 臺大學術典藏 |
2020-03-05T03:20:03Z |
Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy
|
Cheung C.H.Y.;Hsu C.-L.;Tsuei C.-Y.;Kuo T.-T.;Huang C.-T.;Wen-Ming Hsu;Chung Y.-H.;Wu H.-Y.;Hsu C.-C.;Huang H.-C.;Juan H.-F.; Cheung C.H.Y.; Hsu C.-L.; Tsuei C.-Y.; Kuo T.-T.; Huang C.-T.; WEN-MING HSU; Chung Y.-H.; Wu H.-Y.; Hsu C.-C.; Huang H.-C.; Juan H.-F. |
| 臺大學術典藏 |
2020-03-05T03:20:03Z |
Quantitative Proteomics of Th-MYCN Transgenic Mice Reveals Aurora Kinase Inhibitor Altered Metabolic Pathways and Enhanced ACADM to Suppress Neuroblastoma Progression
|
Hsieh C.-H.; Cheung C.H.Y.; Liu Y.-L.; Hou C.-L.; Hsu C.-L.; Huang C.-T.; Yang T.-S.; Chen S.-F.; Chen C.-N.; WEN-MING HSU; Huang H.-C.; Juan H.-F. |
| 臺大學術典藏 |
2020-03-02T06:05:22Z |
Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling
|
Huang M.-J.; Hu R.-H.; Chou C.-H.; Hsu C.-L.; Liu Y.-W.; Huang J.; Hung J.-S.; Lai I.-R.; Juan H.-F.; Yu S.-L.; Wu Y.-M.; MIN-CHUAN HUANG |
| 臺大學術典藏 |
2020-03-02T06:05:21Z |
Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation
|
Juan H.-F.; Hsu C.-L.; MIN-CHUAN HUANG; Lai I.-R.; Hung K.-Y.; Liu S.-Y.; Shun C.-T. |
| 臺大學術典藏 |
2020-03-02T06:05:19Z |
GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity
|
Lin T.-C.; Chen S.-T.; MIN-CHUAN HUANG; Huang J.; Hsu C.-L.; Juan H.-F.; Lin H.-H.; Chen C.-H. |
| 臺大學術典藏 |
2020-03-02T06:05:18Z |
GATA3 interacts with and stabilizes HIF-1α to enhance cancer cell invasiveness
|
Lin M.-C.; Lin J.-J.; Hsu C.-L.; Juan H.-F.; Lou P.-J.; MIN-CHUAN HUANG |
| 臺大學術典藏 |
2020-03-02T06:05:15Z |
C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer
|
Lee P.-C.;Chen S.-T.;Kuo T.-C.;Lin T.-C.;Lin M.-C.;Huang J.;Hung J.-S.;Hsu C.-L.;Juan H.-F.;Lee P.-H.;Min-Chuan Huang; Lee P.-C.; Chen S.-T.; Kuo T.-C.; Lin T.-C.; Lin M.-C.; Huang J.; Hung J.-S.; Hsu C.-L.; Juan H.-F.; Lee P.-H.; MIN-CHUAN HUANG |
| 臺大學術典藏 |
2020-03-02T03:10:45Z |
Analysis of experience-regulated transcriptome and imprintome during critical periods of mouse visual system development reveals spatiotemporal dynamics
|
Hsu C.-L.; Chou C.-H.; Huang S.-C.; Lin C.-Y.; Lin M.-Y.; Tung C.-C.; Lai I.P.; Zou Y.-F.; Youngson N.A.; Lin S.-P.; Yang C.-H.; Chen S.-K.; SUSAN SHUR-FEN GAU; Huang H.-S. |
| 臺大學術典藏 |
2020-02-25T06:21:29Z |
Carrier localization in InN epilayers grown on Si substrates
|
Shu, G. W.; Lo, M. H.; Yang, M. D.; Hsu, C. L.; Shen, J. L.; Lan, S. M.; MIN-HUI LO |
| 臺大學術典藏 |
2020-02-25T05:15:26Z |
Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling
|
Huang M.-C.; Huang M.-J.; Hu R.-H.; Chou C.-H.; Hsu C.-L.; Liu Y.-W.; Huang J.; JI-SHIANG HUNG; Lai I.-R.; Juan H.-F.; Yu S.-L.; Wu Y.-M. |
| 臺大學術典藏 |
2020-02-25T05:15:24Z |
C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer
|
Lee P.-C.;Chen S.-T.;Kuo T.-C.;Lin T.-C.;Lin M.-C.;Huang J.;Ji-Shiang Hung;Hsu C.-L.;Juan H.-F.;Lee P.-H.;Huang M.-C.; Lee P.-C.; Chen S.-T.; Kuo T.-C.; Lin T.-C.; Lin M.-C.; Huang J.; JI-SHIANG HUNG; Hsu C.-L.; Juan H.-F.; Lee P.-H.; Huang M.-C. |
| 臺大學術典藏 |
2020-02-24T01:33:40Z |
Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma
|
Shen Y.-C.;Hsu C.-L.;Jeng Y.-M.;Ho M.-C.;Ho C.-M.;Yeh C.-P.;Yeh C.-Y.;Hsu M.-C.;Rey-Heng Hu;Cheng A.-L.; Shen Y.-C.; Hsu C.-L.; Jeng Y.-M.; Ho M.-C.; Ho C.-M.; Yeh C.-P.; Yeh C.-Y.; Hsu M.-C.; REY-HENG HU; Cheng A.-L. |
| 臺大學術典藏 |
2020-02-20T02:57:00Z |
Cautious application of pleural N-terminal pro-B-type natriuretic peptide in diagnosis of congestive heart failure pleural effusions among critically ill patients
|
Yeh J.-H.; Huang C.-T.; Liu C.-H.; Ruan S.-Y.; Tsai Y.-J.; Chien Y.-C.; CHING-YAO YANG; Huang C.-K.; Hsu C.-L.; Kuo L.-C.; Lee P.-L.; Ku S.-C.; Kuo P.-H.; Yu C.-J.; HINT Study Group |
